Reducing Readmissions

Patient experience and readmissions are tied directly to medication drug trial and error methodology. Symptoms, complaints and interpreting the true nature of a patient's condition is complicated when time and resources are stretched. Fortunately, people's one-of-a-kind DNA communicates the way a body metabolizes medications decreasing the time necessary to become therapeutic while reducing the overall occurrences of Adverse Drug Events (ADE). Both are critical in reducing the time spent in the hospital and lowering readmission rates, thereby improving the bottom line.